Neusspray Xylometazoline Hcl Etos (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Neusspray Xylometazoline Hcl Etos, is an alpha‑adrenergic agonist presented as a nasal spray for nasal use. It relieves nasal congestion associated with the common cold, sinusitis and other upper‑respiratory conditions in both adults and children.

GNH USA supplies Neusspray Xylometazoline Hcl Etos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare facilities across multiple continents worldwide. The product meets EU quality standards and is manufactured under strict GMP conditions.

Xylometazoline Hydrochloride is employed as a topical nasal decongestant to reduce swelling of the nasal mucosa in various upper‑respiratory conditions.

- Nasal congestion: provides rapid relief of blocked nasal passages. - Common cold: alleviates congestion symptoms associated with viral upper‑respiratory infection. - Sinusitis: reduces mucosal edema to improve sinus drainage and ease breathing. - Allergic rhinitis: helps relieve nasal blockage caused by allergic inflammation.

Xylometazoline Hydrochloride may cause local and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Nasal irritation or burning sensation - Dryness of the nasal mucosa - Sneezing - Headache - Altered taste sensation - Mild epistaxis (nosebleed)

Serious or Rare Side Effects: - Rebound nasal congestion (rhinitis medicamentosa) with prolonged use - Severe hypertension - Cardiac arrhythmias - Nasal ulceration or perforation - Anaphylactic reaction - Profuse nosebleeds

When using Neusspray Xylometazoline Hcl Etos, several precautions should be observed to ensure safe and effective therapy.

- Age limitation: not recommended for children under 6 years without medical advice. - Duration of use: limit treatment to 3‑5 days to avoid rebound congestion. - Cardiovascular conditions: use cautiously in patients with hypertension or heart disease. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Drug interactions: avoid concomitant use with monoamine oxidase inhibitors. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with other medicines, altering its effect or increasing the risk of adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: may precipitate hypertensive crisis. - Systemic decongestants (e.g., pseudoephedrine): additive vasoconstrictive effect. - Alpha‑adrenergic eye drops: increased systemic adrenergic activity.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure control. - Tricyclic antidepressants: potential additive cardiovascular stimulation. - Beta‑blockers: monitor for elevated blood pressure or heart rate changes.